Daiwa Securities Group
PTGX icon

Daiwa Securities Group’s Protagonist Therapeutics PTGX Stock Holding History

Daiwa Securities Group’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-190
Closed -$17K – 1383
2025
Q4 		$17K Hold
190
– – ﹤0.01% 1163
2025
Q3 		$13K Sell
190
-25
-12% -$1.42K ﹤0.01% 1147
2025
Q2 		$12K Hold
215
– – ﹤0.01% 1114
2025
Q1 		$10K Hold
215
– – ﹤0.01% 1098
2024
Q4 		$8K Hold
215
– – ﹤0.01% 1135
2024
Q3 		$10K Hold
215
– – ﹤0.01% 1132
2024
Q2 		$7K Hold
215
– – ﹤0.01% 1179
2024
Q1 		$6K Buy
215
+52
+32% +$1.42K ﹤0.01% 1196
2023
Q4 		$4K Hold
163
– – ﹤0.01% 1231
2023
Q3 		$3K Hold
163
– – ﹤0.01% 1202
2023
Q2 		$5K Hold
163
– – ﹤0.01% 1183
2023
Q1 		$4K Hold
163
– – ﹤0.01% 1166
2022
Q4 		$2K Hold
163
– – ﹤0.01% 1234
2022
Q3 		$1K Hold
163
– – ﹤0.01% 1309
2022
Q2 		$1K Hold
163
– – ﹤0.01% 1316
2022
Q1 		$4K Hold
163
– – ﹤0.01% 1199
2021
Q4 		$6K Hold
163
– – ﹤0.01% 1184
2021
Q3 		$3K Buy
163
+82
+101% +$3.5K ﹤0.01% 1224
2021
Q2 		$4K Hold
81
– – ﹤0.01% 1094
2021
Q1 		$2K Hold
81
– – ﹤0.01% 1157
2020
Q4 		$2K Sell
81
-115
-59% -$2.48K ﹤0.01% 1133
2020
Q3 		$4K Buy
196
+42
+27% +$788 ﹤0.01% 1104
2020
Q2 		$1K Hold
154
– – ﹤0.01% 1192
2020
Q1 		$1K Hold
154
– – ﹤0.01% 1196
2019
Q4 		$1K Buy
+154
New +$1.53K ﹤0.01% 1188

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Daiwa Securities Group's PTGX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Protagonist Therapeutics (PTGX) in Q1 2026, closing a stake of 190 shares — an estimated $17K sold.

Daiwa Securities Group first reported a position in PTGX in Q4 2019 and held it in 25 quarters. The position peaked at $17K in Q4 2025. 320 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Protagonist Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 190 Protagonist Therapeutics shares in Q1 2026, an estimated $17K.
  • Daiwa Securities Group first reported a position in Protagonist Therapeutics in Q4 2019 and held it in 25 quarters.
  • Daiwa Securities Group's Protagonist Therapeutics position peaked at $17K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.